sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 21/03/2011
PIL Depakote tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 07/01/2011 and displayed until 21/03/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
Updated on 04/10/2010 and displayed until 07/01/2011
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 18/08/2009 and displayed until 04/10/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 23/07/2008 and displayed until 18/08/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 04/07/2007 and displayed until 23/07/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 18/08/2006 and displayed until 04/07/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 11/05/2004 and displayed until 18/08/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 16/10/2002 and displayed until 11/05/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   valproate semisodium